nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—ABCG2—lung cancer	0.134	0.455	CbGaD
Lansoprazole—CYP1A1—lung cancer	0.105	0.356	CbGaD
Lansoprazole—MAPT—Paclitaxel—lung cancer	0.099	0.204	CbGbCtD
Lansoprazole—MAPT—Docetaxel—lung cancer	0.0716	0.147	CbGbCtD
Lansoprazole—ABCB1—lung cancer	0.0556	0.189	CbGaD
Lansoprazole—CYP4A11—Cisplatin—lung cancer	0.0304	0.0625	CbGbCtD
Lansoprazole—CYP1B1—Erlotinib—lung cancer	0.0171	0.0353	CbGbCtD
Lansoprazole—CYP1B1—Paclitaxel—lung cancer	0.0157	0.0323	CbGbCtD
Lansoprazole—ABCG2—Topotecan—lung cancer	0.0151	0.031	CbGbCtD
Lansoprazole—ABCG2—Gefitinib—lung cancer	0.0138	0.0283	CbGbCtD
Lansoprazole—ABCG2—Teniposide—lung cancer	0.0134	0.0275	CbGbCtD
Lansoprazole—CYP1A1—Gefitinib—lung cancer	0.0127	0.0262	CbGbCtD
Lansoprazole—CYP1B1—Docetaxel—lung cancer	0.0113	0.0233	CbGbCtD
Lansoprazole—CYP1B1—Doxorubicin—lung cancer	0.00846	0.0174	CbGbCtD
Lansoprazole—ABCG2—Erlotinib—lung cancer	0.00815	0.0168	CbGbCtD
Lansoprazole—CYP1A1—Erlotinib—lung cancer	0.00753	0.0155	CbGbCtD
Lansoprazole—ABCG2—Paclitaxel—lung cancer	0.00746	0.0153	CbGbCtD
Lansoprazole—ABCG2—Irinotecan—lung cancer	0.00736	0.0151	CbGbCtD
Lansoprazole—CYP2C19—Gefitinib—lung cancer	0.00616	0.0127	CbGbCtD
Lansoprazole—ABCG2—Cisplatin—lung cancer	0.006	0.0123	CbGbCtD
Lansoprazole—CYP2C19—Teniposide—lung cancer	0.00597	0.0123	CbGbCtD
Lansoprazole—ABCG2—Etoposide—lung cancer	0.0059	0.0121	CbGbCtD
Lansoprazole—ABCB1—Topotecan—lung cancer	0.00544	0.0112	CbGbCtD
Lansoprazole—ABCG2—Docetaxel—lung cancer	0.0054	0.0111	CbGbCtD
Lansoprazole—CYP2C9—Gefitinib—lung cancer	0.00512	0.0105	CbGbCtD
Lansoprazole—ABCB1—Gefitinib—lung cancer	0.00497	0.0102	CbGbCtD
Lansoprazole—CYP2C9—Teniposide—lung cancer	0.00497	0.0102	CbGbCtD
Lansoprazole—CYP2D6—Gefitinib—lung cancer	0.00468	0.00963	CbGbCtD
Lansoprazole—CYP2C8—Erlotinib—lung cancer	0.00434	0.00893	CbGbCtD
Lansoprazole—ABCG2—Doxorubicin—lung cancer	0.00402	0.00827	CbGbCtD
Lansoprazole—CYP2C8—Paclitaxel—lung cancer	0.00398	0.00817	CbGbCtD
Lansoprazole—ABCG2—Methotrexate—lung cancer	0.0039	0.00801	CbGbCtD
Lansoprazole—ABCB1—Vinorelbine—lung cancer	0.00383	0.00787	CbGbCtD
Lansoprazole—CYP2D6—Vinorelbine—lung cancer	0.00361	0.00742	CbGbCtD
Lansoprazole—CYP1A2—Erlotinib—lung cancer	0.00336	0.00691	CbGbCtD
Lansoprazole—CYP3A4—Topotecan—lung cancer	0.00326	0.0067	CbGbCtD
Lansoprazole—CYP2C8—Etoposide—lung cancer	0.00314	0.00646	CbGbCtD
Lansoprazole—ABCB1—Crizotinib—lung cancer	0.00305	0.00626	CbGbCtD
Lansoprazole—CYP3A4—Gefitinib—lung cancer	0.00298	0.00612	CbGbCtD
Lansoprazole—ABCB1—Gemcitabine—lung cancer	0.00298	0.00612	CbGbCtD
Lansoprazole—ABCB1—Erlotinib—lung cancer	0.00294	0.00604	CbGbCtD
Lansoprazole—CYP3A4—Teniposide—lung cancer	0.00289	0.00594	CbGbCtD
Lansoprazole—CYP2C9—Paclitaxel—lung cancer	0.00277	0.0057	CbGbCtD
Lansoprazole—CYP2D6—Erlotinib—lung cancer	0.00277	0.00569	CbGbCtD
Lansoprazole—ABCB1—Paclitaxel—lung cancer	0.00269	0.00553	CbGbCtD
Lansoprazole—ABCB1—Irinotecan—lung cancer	0.00265	0.00546	CbGbCtD
Lansoprazole—CYP1A2—Etoposide—lung cancer	0.00243	0.005	CbGbCtD
Lansoprazole—ABCB1—Vinblastine—lung cancer	0.00236	0.00485	CbGbCtD
Lansoprazole—CYP3A4—Vinorelbine—lung cancer	0.00229	0.00472	CbGbCtD
Lansoprazole—CYP2C9—Cisplatin—lung cancer	0.00223	0.00458	CbGbCtD
Lansoprazole—CYP2D6—Vinblastine—lung cancer	0.00222	0.00457	CbGbCtD
Lansoprazole—ABCB1—Cisplatin—lung cancer	0.00216	0.00445	CbGbCtD
Lansoprazole—ABCB1—Etoposide—lung cancer	0.00213	0.00437	CbGbCtD
Lansoprazole—ABCB1—Docetaxel—lung cancer	0.00195	0.004	CbGbCtD
Lansoprazole—CYP3A4—Crizotinib—lung cancer	0.00183	0.00375	CbGbCtD
Lansoprazole—CYP3A4—Erlotinib—lung cancer	0.00176	0.00362	CbGbCtD
Lansoprazole—CYP3A4—Paclitaxel—lung cancer	0.00161	0.00331	CbGbCtD
Lansoprazole—CYP3A4—Irinotecan—lung cancer	0.00159	0.00327	CbGbCtD
Lansoprazole—ABCB1—Doxorubicin—lung cancer	0.00145	0.00298	CbGbCtD
Lansoprazole—CYP3A4—Vinblastine—lung cancer	0.00141	0.00291	CbGbCtD
Lansoprazole—ABCB1—Methotrexate—lung cancer	0.0014	0.00289	CbGbCtD
Lansoprazole—CYP2D6—Doxorubicin—lung cancer	0.00137	0.00281	CbGbCtD
Lansoprazole—CYP3A4—Etoposide—lung cancer	0.00127	0.00262	CbGbCtD
Lansoprazole—CYP3A4—Docetaxel—lung cancer	0.00117	0.0024	CbGbCtD
Lansoprazole—Thiabendazole—CYP1A1—lung cancer	0.000874	0.272	CrCbGaD
Lansoprazole—CYP3A4—Doxorubicin—lung cancer	0.000869	0.00179	CbGbCtD
Lansoprazole—Omeprazole—ABCC3—lung cancer	0.000589	0.183	CrCbGaD
Lansoprazole—Rabeprazole—ABCG2—lung cancer	0.000351	0.109	CrCbGaD
Lansoprazole—Pantoprazole—ABCG2—lung cancer	0.000351	0.109	CrCbGaD
Lansoprazole—Omeprazole—ABCG2—lung cancer	0.000286	0.089	CrCbGaD
Lansoprazole—Rabeprazole—CYP1A1—lung cancer	0.000275	0.0855	CrCbGaD
Lansoprazole—Omeprazole—CYP1A1—lung cancer	0.000224	0.0697	CrCbGaD
Lansoprazole—ATP4A—respiratory system—lung cancer	0.000208	0.124	CbGeAlD
Lansoprazole—ATP4A—epithelium—lung cancer	0.000174	0.103	CbGeAlD
Lansoprazole—Pantoprazole—ABCB1—lung cancer	0.000146	0.0455	CrCbGaD
Lansoprazole—CYP2C18—bronchus—lung cancer	0.000141	0.0836	CbGeAlD
Lansoprazole—CYP1B1—mammary gland—lung cancer	0.000124	0.0739	CbGeAlD
Lansoprazole—Omeprazole—ABCB1—lung cancer	0.000119	0.0371	CrCbGaD
Lansoprazole—MAPT—lymph node—lung cancer	0.000102	0.0605	CbGeAlD
Lansoprazole—CYP2C8—mammary gland—lung cancer	9.51e-05	0.0566	CbGeAlD
Lansoprazole—CYP2C9—mammary gland—lung cancer	8.45e-05	0.0502	CbGeAlD
Lansoprazole—CYP1B1—respiratory system—lung cancer	8.28e-05	0.0492	CbGeAlD
Lansoprazole—CYP1A2—respiratory system—lung cancer	5.93e-05	0.0353	CbGeAlD
Lansoprazole—CYP1A1—respiratory system—lung cancer	5.85e-05	0.0348	CbGeAlD
Lansoprazole—CYP1A1—epithelium—lung cancer	4.89e-05	0.0291	CbGeAlD
Lansoprazole—CYP1A1—bronchus—lung cancer	4.82e-05	0.0286	CbGeAlD
Lansoprazole—CYP1B1—lung—lung cancer	4.39e-05	0.0261	CbGeAlD
Lansoprazole—CYP1A1—trachea—lung cancer	4.32e-05	0.0257	CbGeAlD
Lansoprazole—CYP1A1—cardiac atrium—lung cancer	4.06e-05	0.0242	CbGeAlD
Lansoprazole—ABCG2—bone marrow—lung cancer	3.61e-05	0.0215	CbGeAlD
Lansoprazole—ABCG2—lung—lung cancer	3.27e-05	0.0195	CbGeAlD
Lansoprazole—CYP1A2—lung—lung cancer	3.15e-05	0.0187	CbGeAlD
Lansoprazole—CYP1A1—lung—lung cancer	3.11e-05	0.0185	CbGeAlD
Lansoprazole—ABCB1—respiratory system—lung cancer	3.04e-05	0.0181	CbGeAlD
Lansoprazole—CYP1B1—lymph node—lung cancer	3.01e-05	0.0179	CbGeAlD
Lansoprazole—Urethral disorder—Methotrexate—lung cancer	2.75e-05	0.00021	CcSEcCtD
Lansoprazole—Infection—Docetaxel—lung cancer	2.74e-05	0.00021	CcSEcCtD
Lansoprazole—Feeling abnormal—Etoposide—lung cancer	2.74e-05	0.000209	CcSEcCtD
Lansoprazole—Hyperglycaemia—Doxorubicin—lung cancer	2.73e-05	0.000209	CcSEcCtD
Lansoprazole—Diarrhoea—Irinotecan—lung cancer	2.73e-05	0.000209	CcSEcCtD
Lansoprazole—Pneumonia—Doxorubicin—lung cancer	2.72e-05	0.000208	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Etoposide—lung cancer	2.72e-05	0.000208	CcSEcCtD
Lansoprazole—Shock—Docetaxel—lung cancer	2.72e-05	0.000208	CcSEcCtD
Lansoprazole—Nervous system disorder—Docetaxel—lung cancer	2.71e-05	0.000207	CcSEcCtD
Lansoprazole—Thrombocytopenia—Docetaxel—lung cancer	2.7e-05	0.000207	CcSEcCtD
Lansoprazole—Infestation—Doxorubicin—lung cancer	2.7e-05	0.000207	CcSEcCtD
Lansoprazole—Infestation NOS—Doxorubicin—lung cancer	2.7e-05	0.000207	CcSEcCtD
Lansoprazole—Visual impairment—Methotrexate—lung cancer	2.7e-05	0.000207	CcSEcCtD
Lansoprazole—Tachycardia—Docetaxel—lung cancer	2.69e-05	0.000206	CcSEcCtD
Lansoprazole—Feeling abnormal—Paclitaxel—lung cancer	2.68e-05	0.000205	CcSEcCtD
Lansoprazole—Skin disorder—Docetaxel—lung cancer	2.68e-05	0.000205	CcSEcCtD
Lansoprazole—Stevens-Johnson syndrome—Doxorubicin—lung cancer	2.68e-05	0.000205	CcSEcCtD
Lansoprazole—Hypersensitivity—Cisplatin—lung cancer	2.67e-05	0.000204	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Paclitaxel—lung cancer	2.66e-05	0.000204	CcSEcCtD
Lansoprazole—Diarrhoea—Gemcitabine—lung cancer	2.66e-05	0.000204	CcSEcCtD
Lansoprazole—Renal failure—Doxorubicin—lung cancer	2.66e-05	0.000203	CcSEcCtD
Lansoprazole—Erythema multiforme—Methotrexate—lung cancer	2.65e-05	0.000203	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Doxorubicin—lung cancer	2.65e-05	0.000203	CcSEcCtD
Lansoprazole—Dizziness—Irinotecan—lung cancer	2.64e-05	0.000202	CcSEcCtD
Lansoprazole—Urticaria—Etoposide—lung cancer	2.64e-05	0.000202	CcSEcCtD
Lansoprazole—Jaundice—Doxorubicin—lung cancer	2.63e-05	0.000201	CcSEcCtD
Lansoprazole—Stomatitis—Doxorubicin—lung cancer	2.63e-05	0.000201	CcSEcCtD
Lansoprazole—Anorexia—Docetaxel—lung cancer	2.63e-05	0.000201	CcSEcCtD
Lansoprazole—Body temperature increased—Etoposide—lung cancer	2.63e-05	0.000201	CcSEcCtD
Lansoprazole—Abdominal pain—Etoposide—lung cancer	2.63e-05	0.000201	CcSEcCtD
Lansoprazole—Conjunctivitis—Doxorubicin—lung cancer	2.63e-05	0.000201	CcSEcCtD
Lansoprazole—Urinary tract infection—Doxorubicin—lung cancer	2.63e-05	0.000201	CcSEcCtD
Lansoprazole—Eye disorder—Methotrexate—lung cancer	2.62e-05	0.0002	CcSEcCtD
Lansoprazole—Tinnitus—Methotrexate—lung cancer	2.61e-05	0.0002	CcSEcCtD
Lansoprazole—Asthenia—Cisplatin—lung cancer	2.6e-05	0.000199	CcSEcCtD
Lansoprazole—Cardiac disorder—Methotrexate—lung cancer	2.6e-05	0.000199	CcSEcCtD
Lansoprazole—Sweating—Doxorubicin—lung cancer	2.59e-05	0.000198	CcSEcCtD
Lansoprazole—Urticaria—Paclitaxel—lung cancer	2.59e-05	0.000198	CcSEcCtD
Lansoprazole—Hypotension—Docetaxel—lung cancer	2.58e-05	0.000197	CcSEcCtD
Lansoprazole—Haematuria—Doxorubicin—lung cancer	2.58e-05	0.000197	CcSEcCtD
Lansoprazole—Body temperature increased—Paclitaxel—lung cancer	2.57e-05	0.000197	CcSEcCtD
Lansoprazole—Abdominal pain—Paclitaxel—lung cancer	2.57e-05	0.000197	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Doxorubicin—lung cancer	2.55e-05	0.000195	CcSEcCtD
Lansoprazole—Epistaxis—Doxorubicin—lung cancer	2.55e-05	0.000195	CcSEcCtD
Lansoprazole—Angiopathy—Methotrexate—lung cancer	2.54e-05	0.000194	CcSEcCtD
Lansoprazole—ABCB1—epithelium—lung cancer	2.54e-05	0.0151	CbGeAlD
Lansoprazole—Vomiting—Irinotecan—lung cancer	2.54e-05	0.000194	CcSEcCtD
Lansoprazole—Sinusitis—Doxorubicin—lung cancer	2.53e-05	0.000194	CcSEcCtD
Lansoprazole—Immune system disorder—Methotrexate—lung cancer	2.53e-05	0.000194	CcSEcCtD
Lansoprazole—Mediastinal disorder—Methotrexate—lung cancer	2.52e-05	0.000193	CcSEcCtD
Lansoprazole—Agranulocytosis—Doxorubicin—lung cancer	2.52e-05	0.000193	CcSEcCtD
Lansoprazole—Rash—Irinotecan—lung cancer	2.52e-05	0.000193	CcSEcCtD
Lansoprazole—Dermatitis—Irinotecan—lung cancer	2.52e-05	0.000192	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Docetaxel—lung cancer	2.52e-05	0.000192	CcSEcCtD
Lansoprazole—Chills—Methotrexate—lung cancer	2.51e-05	0.000192	CcSEcCtD
Lansoprazole—Headache—Irinotecan—lung cancer	2.5e-05	0.000191	CcSEcCtD
Lansoprazole—Insomnia—Docetaxel—lung cancer	2.5e-05	0.000191	CcSEcCtD
Lansoprazole—Diarrhoea—Cisplatin—lung cancer	2.48e-05	0.00019	CcSEcCtD
Lansoprazole—Paraesthesia—Docetaxel—lung cancer	2.48e-05	0.00019	CcSEcCtD
Lansoprazole—Alopecia—Methotrexate—lung cancer	2.47e-05	0.000189	CcSEcCtD
Lansoprazole—Vomiting—Gemcitabine—lung cancer	2.47e-05	0.000189	CcSEcCtD
Lansoprazole—Bradycardia—Doxorubicin—lung cancer	2.47e-05	0.000189	CcSEcCtD
Lansoprazole—Dyspnoea—Docetaxel—lung cancer	2.46e-05	0.000188	CcSEcCtD
Lansoprazole—Somnolence—Docetaxel—lung cancer	2.45e-05	0.000188	CcSEcCtD
Lansoprazole—Mental disorder—Methotrexate—lung cancer	2.45e-05	0.000188	CcSEcCtD
Lansoprazole—Rash—Gemcitabine—lung cancer	2.45e-05	0.000188	CcSEcCtD
Lansoprazole—Dermatitis—Gemcitabine—lung cancer	2.45e-05	0.000188	CcSEcCtD
Lansoprazole—Hypersensitivity—Etoposide—lung cancer	2.45e-05	0.000187	CcSEcCtD
Lansoprazole—Malnutrition—Methotrexate—lung cancer	2.44e-05	0.000187	CcSEcCtD
Lansoprazole—Erythema—Methotrexate—lung cancer	2.44e-05	0.000187	CcSEcCtD
Lansoprazole—Headache—Gemcitabine—lung cancer	2.44e-05	0.000186	CcSEcCtD
Lansoprazole—Rhinitis—Doxorubicin—lung cancer	2.43e-05	0.000186	CcSEcCtD
Lansoprazole—Dyspepsia—Docetaxel—lung cancer	2.43e-05	0.000186	CcSEcCtD
Lansoprazole—Hepatitis—Doxorubicin—lung cancer	2.42e-05	0.000186	CcSEcCtD
Lansoprazole—Hypoaesthesia—Doxorubicin—lung cancer	2.41e-05	0.000185	CcSEcCtD
Lansoprazole—Pharyngitis—Doxorubicin—lung cancer	2.41e-05	0.000184	CcSEcCtD
Lansoprazole—Decreased appetite—Docetaxel—lung cancer	2.4e-05	0.000184	CcSEcCtD
Lansoprazole—Hypersensitivity—Paclitaxel—lung cancer	2.4e-05	0.000184	CcSEcCtD
Lansoprazole—Urinary tract disorder—Doxorubicin—lung cancer	2.39e-05	0.000183	CcSEcCtD
Lansoprazole—Oedema peripheral—Doxorubicin—lung cancer	2.39e-05	0.000183	CcSEcCtD
Lansoprazole—Dysgeusia—Methotrexate—lung cancer	2.39e-05	0.000183	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Docetaxel—lung cancer	2.38e-05	0.000182	CcSEcCtD
Lansoprazole—Asthenia—Etoposide—lung cancer	2.38e-05	0.000182	CcSEcCtD
Lansoprazole—Connective tissue disorder—Doxorubicin—lung cancer	2.38e-05	0.000182	CcSEcCtD
Lansoprazole—Fatigue—Docetaxel—lung cancer	2.38e-05	0.000182	CcSEcCtD
Lansoprazole—Urethral disorder—Doxorubicin—lung cancer	2.38e-05	0.000182	CcSEcCtD
Lansoprazole—Nausea—Irinotecan—lung cancer	2.37e-05	0.000182	CcSEcCtD
Lansoprazole—Constipation—Docetaxel—lung cancer	2.36e-05	0.000181	CcSEcCtD
Lansoprazole—Pain—Docetaxel—lung cancer	2.36e-05	0.000181	CcSEcCtD
Lansoprazole—Back pain—Methotrexate—lung cancer	2.36e-05	0.00018	CcSEcCtD
Lansoprazole—Pruritus—Etoposide—lung cancer	2.35e-05	0.00018	CcSEcCtD
Lansoprazole—Visual impairment—Doxorubicin—lung cancer	2.34e-05	0.000179	CcSEcCtD
Lansoprazole—Asthenia—Paclitaxel—lung cancer	2.34e-05	0.000179	CcSEcCtD
Lansoprazole—Nausea—Gemcitabine—lung cancer	2.31e-05	0.000177	CcSEcCtD
Lansoprazole—Vomiting—Cisplatin—lung cancer	2.31e-05	0.000176	CcSEcCtD
Lansoprazole—Pruritus—Paclitaxel—lung cancer	2.3e-05	0.000176	CcSEcCtD
Lansoprazole—Vision blurred—Methotrexate—lung cancer	2.3e-05	0.000176	CcSEcCtD
Lansoprazole—Erythema multiforme—Doxorubicin—lung cancer	2.29e-05	0.000175	CcSEcCtD
Lansoprazole—Rash—Cisplatin—lung cancer	2.29e-05	0.000175	CcSEcCtD
Lansoprazole—Dermatitis—Cisplatin—lung cancer	2.28e-05	0.000175	CcSEcCtD
Lansoprazole—Feeling abnormal—Docetaxel—lung cancer	2.27e-05	0.000174	CcSEcCtD
Lansoprazole—Diarrhoea—Etoposide—lung cancer	2.27e-05	0.000174	CcSEcCtD
Lansoprazole—Eye disorder—Doxorubicin—lung cancer	2.27e-05	0.000173	CcSEcCtD
Lansoprazole—Ill-defined disorder—Methotrexate—lung cancer	2.26e-05	0.000173	CcSEcCtD
Lansoprazole—Tinnitus—Doxorubicin—lung cancer	2.26e-05	0.000173	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Docetaxel—lung cancer	2.26e-05	0.000173	CcSEcCtD
Lansoprazole—Anaemia—Methotrexate—lung cancer	2.25e-05	0.000172	CcSEcCtD
Lansoprazole—Cardiac disorder—Doxorubicin—lung cancer	2.25e-05	0.000172	CcSEcCtD
Lansoprazole—ABCB1—trachea—lung cancer	2.25e-05	0.0134	CbGeAlD
Lansoprazole—ABCG2—lymph node—lung cancer	2.24e-05	0.0133	CbGeAlD
Lansoprazole—Diarrhoea—Paclitaxel—lung cancer	2.23e-05	0.000171	CcSEcCtD
Lansoprazole—Angiopathy—Doxorubicin—lung cancer	2.2e-05	0.000168	CcSEcCtD
Lansoprazole—Malaise—Methotrexate—lung cancer	2.2e-05	0.000168	CcSEcCtD
Lansoprazole—Dizziness—Etoposide—lung cancer	2.2e-05	0.000168	CcSEcCtD
Lansoprazole—Immune system disorder—Doxorubicin—lung cancer	2.19e-05	0.000168	CcSEcCtD
Lansoprazole—Vertigo—Methotrexate—lung cancer	2.19e-05	0.000168	CcSEcCtD
Lansoprazole—Mediastinal disorder—Doxorubicin—lung cancer	2.19e-05	0.000167	CcSEcCtD
Lansoprazole—Abdominal pain—Docetaxel—lung cancer	2.18e-05	0.000167	CcSEcCtD
Lansoprazole—Body temperature increased—Docetaxel—lung cancer	2.18e-05	0.000167	CcSEcCtD
Lansoprazole—Leukopenia—Methotrexate—lung cancer	2.18e-05	0.000167	CcSEcCtD
Lansoprazole—Chills—Doxorubicin—lung cancer	2.18e-05	0.000167	CcSEcCtD
Lansoprazole—Arrhythmia—Doxorubicin—lung cancer	2.17e-05	0.000166	CcSEcCtD
Lansoprazole—Dizziness—Paclitaxel—lung cancer	2.15e-05	0.000165	CcSEcCtD
Lansoprazole—Nausea—Cisplatin—lung cancer	2.15e-05	0.000165	CcSEcCtD
Lansoprazole—Alopecia—Doxorubicin—lung cancer	2.14e-05	0.000164	CcSEcCtD
Lansoprazole—Cough—Methotrexate—lung cancer	2.13e-05	0.000163	CcSEcCtD
Lansoprazole—CYP1A1—lymph node—lung cancer	2.12e-05	0.0126	CbGeAlD
Lansoprazole—Mental disorder—Doxorubicin—lung cancer	2.12e-05	0.000163	CcSEcCtD
Lansoprazole—Convulsion—Methotrexate—lung cancer	2.11e-05	0.000162	CcSEcCtD
Lansoprazole—Vomiting—Etoposide—lung cancer	2.11e-05	0.000162	CcSEcCtD
Lansoprazole—Erythema—Doxorubicin—lung cancer	2.11e-05	0.000162	CcSEcCtD
Lansoprazole—Malnutrition—Doxorubicin—lung cancer	2.11e-05	0.000162	CcSEcCtD
Lansoprazole—Rash—Etoposide—lung cancer	2.09e-05	0.00016	CcSEcCtD
Lansoprazole—Dermatitis—Etoposide—lung cancer	2.09e-05	0.00016	CcSEcCtD
Lansoprazole—Headache—Etoposide—lung cancer	2.08e-05	0.000159	CcSEcCtD
Lansoprazole—Flatulence—Doxorubicin—lung cancer	2.08e-05	0.000159	CcSEcCtD
Lansoprazole—Myalgia—Methotrexate—lung cancer	2.08e-05	0.000159	CcSEcCtD
Lansoprazole—Chest pain—Methotrexate—lung cancer	2.08e-05	0.000159	CcSEcCtD
Lansoprazole—Arthralgia—Methotrexate—lung cancer	2.08e-05	0.000159	CcSEcCtD
Lansoprazole—Tension—Doxorubicin—lung cancer	2.07e-05	0.000159	CcSEcCtD
Lansoprazole—Vomiting—Paclitaxel—lung cancer	2.07e-05	0.000158	CcSEcCtD
Lansoprazole—Dysgeusia—Doxorubicin—lung cancer	2.07e-05	0.000158	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.06e-05	0.000158	CcSEcCtD
Lansoprazole—Rash—Paclitaxel—lung cancer	2.05e-05	0.000157	CcSEcCtD
Lansoprazole—Dermatitis—Paclitaxel—lung cancer	2.05e-05	0.000157	CcSEcCtD
Lansoprazole—Discomfort—Methotrexate—lung cancer	2.05e-05	0.000157	CcSEcCtD
Lansoprazole—Nervousness—Doxorubicin—lung cancer	2.05e-05	0.000157	CcSEcCtD
Lansoprazole—Back pain—Doxorubicin—lung cancer	2.04e-05	0.000156	CcSEcCtD
Lansoprazole—Headache—Paclitaxel—lung cancer	2.04e-05	0.000156	CcSEcCtD
Lansoprazole—Hypersensitivity—Docetaxel—lung cancer	2.03e-05	0.000156	CcSEcCtD
Lansoprazole—Muscle spasms—Doxorubicin—lung cancer	2.03e-05	0.000155	CcSEcCtD
Lansoprazole—Confusional state—Methotrexate—lung cancer	2.01e-05	0.000154	CcSEcCtD
Lansoprazole—Anaphylactic shock—Methotrexate—lung cancer	1.99e-05	0.000152	CcSEcCtD
Lansoprazole—Vision blurred—Doxorubicin—lung cancer	1.99e-05	0.000152	CcSEcCtD
Lansoprazole—Asthenia—Docetaxel—lung cancer	1.98e-05	0.000152	CcSEcCtD
Lansoprazole—Infection—Methotrexate—lung cancer	1.98e-05	0.000151	CcSEcCtD
Lansoprazole—Nausea—Etoposide—lung cancer	1.97e-05	0.000151	CcSEcCtD
Lansoprazole—Ill-defined disorder—Doxorubicin—lung cancer	1.96e-05	0.00015	CcSEcCtD
Lansoprazole—Pruritus—Docetaxel—lung cancer	1.95e-05	0.000149	CcSEcCtD
Lansoprazole—Nervous system disorder—Methotrexate—lung cancer	1.95e-05	0.000149	CcSEcCtD
Lansoprazole—Anaemia—Doxorubicin—lung cancer	1.95e-05	0.000149	CcSEcCtD
Lansoprazole—Thrombocytopenia—Methotrexate—lung cancer	1.95e-05	0.000149	CcSEcCtD
Lansoprazole—Agitation—Doxorubicin—lung cancer	1.94e-05	0.000148	CcSEcCtD
Lansoprazole—Nausea—Paclitaxel—lung cancer	1.93e-05	0.000148	CcSEcCtD
Lansoprazole—Skin disorder—Methotrexate—lung cancer	1.93e-05	0.000148	CcSEcCtD
Lansoprazole—Hyperhidrosis—Methotrexate—lung cancer	1.92e-05	0.000147	CcSEcCtD
Lansoprazole—Malaise—Doxorubicin—lung cancer	1.9e-05	0.000146	CcSEcCtD
Lansoprazole—Vertigo—Doxorubicin—lung cancer	1.9e-05	0.000145	CcSEcCtD
Lansoprazole—Anorexia—Methotrexate—lung cancer	1.9e-05	0.000145	CcSEcCtD
Lansoprazole—Syncope—Doxorubicin—lung cancer	1.89e-05	0.000145	CcSEcCtD
Lansoprazole—Leukopenia—Doxorubicin—lung cancer	1.89e-05	0.000145	CcSEcCtD
Lansoprazole—Diarrhoea—Docetaxel—lung cancer	1.89e-05	0.000145	CcSEcCtD
Lansoprazole—Palpitations—Doxorubicin—lung cancer	1.87e-05	0.000143	CcSEcCtD
Lansoprazole—Hypotension—Methotrexate—lung cancer	1.86e-05	0.000142	CcSEcCtD
Lansoprazole—Loss of consciousness—Doxorubicin—lung cancer	1.86e-05	0.000142	CcSEcCtD
Lansoprazole—Cough—Doxorubicin—lung cancer	1.84e-05	0.000141	CcSEcCtD
Lansoprazole—Convulsion—Doxorubicin—lung cancer	1.83e-05	0.00014	CcSEcCtD
Lansoprazole—Dizziness—Docetaxel—lung cancer	1.83e-05	0.00014	CcSEcCtD
Lansoprazole—Hypertension—Doxorubicin—lung cancer	1.82e-05	0.000139	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Methotrexate—lung cancer	1.81e-05	0.000139	CcSEcCtD
Lansoprazole—Insomnia—Methotrexate—lung cancer	1.8e-05	0.000138	CcSEcCtD
Lansoprazole—Chest pain—Doxorubicin—lung cancer	1.8e-05	0.000138	CcSEcCtD
Lansoprazole—Arthralgia—Doxorubicin—lung cancer	1.8e-05	0.000138	CcSEcCtD
Lansoprazole—Myalgia—Doxorubicin—lung cancer	1.8e-05	0.000138	CcSEcCtD
Lansoprazole—Anxiety—Doxorubicin—lung cancer	1.79e-05	0.000137	CcSEcCtD
Lansoprazole—Paraesthesia—Methotrexate—lung cancer	1.79e-05	0.000137	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	1.78e-05	0.000137	CcSEcCtD
Lansoprazole—ABCB1—bone marrow—lung cancer	1.78e-05	0.0106	CbGeAlD
Lansoprazole—Discomfort—Doxorubicin—lung cancer	1.78e-05	0.000136	CcSEcCtD
Lansoprazole—Dyspnoea—Methotrexate—lung cancer	1.77e-05	0.000136	CcSEcCtD
Lansoprazole—Somnolence—Methotrexate—lung cancer	1.77e-05	0.000135	CcSEcCtD
Lansoprazole—Dry mouth—Doxorubicin—lung cancer	1.76e-05	0.000134	CcSEcCtD
Lansoprazole—Vomiting—Docetaxel—lung cancer	1.76e-05	0.000134	CcSEcCtD
Lansoprazole—Dyspepsia—Methotrexate—lung cancer	1.75e-05	0.000134	CcSEcCtD
Lansoprazole—Rash—Docetaxel—lung cancer	1.74e-05	0.000133	CcSEcCtD
Lansoprazole—Dermatitis—Docetaxel—lung cancer	1.74e-05	0.000133	CcSEcCtD
Lansoprazole—Confusional state—Doxorubicin—lung cancer	1.74e-05	0.000133	CcSEcCtD
Lansoprazole—Decreased appetite—Methotrexate—lung cancer	1.73e-05	0.000132	CcSEcCtD
Lansoprazole—Headache—Docetaxel—lung cancer	1.73e-05	0.000132	CcSEcCtD
Lansoprazole—Anaphylactic shock—Doxorubicin—lung cancer	1.72e-05	0.000132	CcSEcCtD
Lansoprazole—Oedema—Doxorubicin—lung cancer	1.72e-05	0.000132	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Methotrexate—lung cancer	1.72e-05	0.000131	CcSEcCtD
Lansoprazole—Fatigue—Methotrexate—lung cancer	1.72e-05	0.000131	CcSEcCtD
Lansoprazole—Infection—Doxorubicin—lung cancer	1.71e-05	0.000131	CcSEcCtD
Lansoprazole—Pain—Methotrexate—lung cancer	1.7e-05	0.00013	CcSEcCtD
Lansoprazole—Shock—Doxorubicin—lung cancer	1.69e-05	0.00013	CcSEcCtD
Lansoprazole—Nervous system disorder—Doxorubicin—lung cancer	1.69e-05	0.000129	CcSEcCtD
Lansoprazole—Thrombocytopenia—Doxorubicin—lung cancer	1.69e-05	0.000129	CcSEcCtD
Lansoprazole—Tachycardia—Doxorubicin—lung cancer	1.68e-05	0.000129	CcSEcCtD
Lansoprazole—Skin disorder—Doxorubicin—lung cancer	1.67e-05	0.000128	CcSEcCtD
Lansoprazole—Hyperhidrosis—Doxorubicin—lung cancer	1.67e-05	0.000127	CcSEcCtD
Lansoprazole—Anorexia—Doxorubicin—lung cancer	1.64e-05	0.000126	CcSEcCtD
Lansoprazole—Nausea—Docetaxel—lung cancer	1.64e-05	0.000125	CcSEcCtD
Lansoprazole—Feeling abnormal—Methotrexate—lung cancer	1.64e-05	0.000125	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Methotrexate—lung cancer	1.63e-05	0.000125	CcSEcCtD
Lansoprazole—ABCB1—lung—lung cancer	1.61e-05	0.0096	CbGeAlD
Lansoprazole—Hypotension—Doxorubicin—lung cancer	1.61e-05	0.000123	CcSEcCtD
Lansoprazole—Urticaria—Methotrexate—lung cancer	1.58e-05	0.000121	CcSEcCtD
Lansoprazole—Body temperature increased—Methotrexate—lung cancer	1.57e-05	0.00012	CcSEcCtD
Lansoprazole—Abdominal pain—Methotrexate—lung cancer	1.57e-05	0.00012	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.57e-05	0.00012	CcSEcCtD
Lansoprazole—Insomnia—Doxorubicin—lung cancer	1.56e-05	0.000119	CcSEcCtD
Lansoprazole—Paraesthesia—Doxorubicin—lung cancer	1.55e-05	0.000118	CcSEcCtD
Lansoprazole—Dyspnoea—Doxorubicin—lung cancer	1.54e-05	0.000118	CcSEcCtD
Lansoprazole—Somnolence—Doxorubicin—lung cancer	1.53e-05	0.000117	CcSEcCtD
Lansoprazole—Dyspepsia—Doxorubicin—lung cancer	1.52e-05	0.000116	CcSEcCtD
Lansoprazole—Decreased appetite—Doxorubicin—lung cancer	1.5e-05	0.000115	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Doxorubicin—lung cancer	1.49e-05	0.000114	CcSEcCtD
Lansoprazole—Fatigue—Doxorubicin—lung cancer	1.49e-05	0.000114	CcSEcCtD
Lansoprazole—Pain—Doxorubicin—lung cancer	1.47e-05	0.000113	CcSEcCtD
Lansoprazole—Constipation—Doxorubicin—lung cancer	1.47e-05	0.000113	CcSEcCtD
Lansoprazole—Hypersensitivity—Methotrexate—lung cancer	1.47e-05	0.000112	CcSEcCtD
Lansoprazole—Asthenia—Methotrexate—lung cancer	1.43e-05	0.000109	CcSEcCtD
Lansoprazole—Feeling abnormal—Doxorubicin—lung cancer	1.42e-05	0.000109	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Doxorubicin—lung cancer	1.41e-05	0.000108	CcSEcCtD
Lansoprazole—Pruritus—Methotrexate—lung cancer	1.41e-05	0.000108	CcSEcCtD
Lansoprazole—Urticaria—Doxorubicin—lung cancer	1.37e-05	0.000105	CcSEcCtD
Lansoprazole—Abdominal pain—Doxorubicin—lung cancer	1.36e-05	0.000104	CcSEcCtD
Lansoprazole—Body temperature increased—Doxorubicin—lung cancer	1.36e-05	0.000104	CcSEcCtD
Lansoprazole—Diarrhoea—Methotrexate—lung cancer	1.36e-05	0.000104	CcSEcCtD
Lansoprazole—Dizziness—Methotrexate—lung cancer	1.32e-05	0.000101	CcSEcCtD
Lansoprazole—Hypersensitivity—Doxorubicin—lung cancer	1.27e-05	9.71e-05	CcSEcCtD
Lansoprazole—Vomiting—Methotrexate—lung cancer	1.27e-05	9.68e-05	CcSEcCtD
Lansoprazole—Rash—Methotrexate—lung cancer	1.25e-05	9.6e-05	CcSEcCtD
Lansoprazole—Dermatitis—Methotrexate—lung cancer	1.25e-05	9.59e-05	CcSEcCtD
Lansoprazole—Headache—Methotrexate—lung cancer	1.25e-05	9.54e-05	CcSEcCtD
Lansoprazole—Asthenia—Doxorubicin—lung cancer	1.24e-05	9.46e-05	CcSEcCtD
Lansoprazole—Pruritus—Doxorubicin—lung cancer	1.22e-05	9.33e-05	CcSEcCtD
Lansoprazole—Nausea—Methotrexate—lung cancer	1.18e-05	9.04e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Doxorubicin—lung cancer	1.18e-05	9.02e-05	CcSEcCtD
Lansoprazole—Dizziness—Doxorubicin—lung cancer	1.14e-05	8.72e-05	CcSEcCtD
Lansoprazole—ABCB1—lymph node—lung cancer	1.1e-05	0.00656	CbGeAlD
Lansoprazole—Vomiting—Doxorubicin—lung cancer	1.1e-05	8.38e-05	CcSEcCtD
Lansoprazole—Rash—Doxorubicin—lung cancer	1.09e-05	8.31e-05	CcSEcCtD
Lansoprazole—Dermatitis—Doxorubicin—lung cancer	1.09e-05	8.3e-05	CcSEcCtD
Lansoprazole—Headache—Doxorubicin—lung cancer	1.08e-05	8.26e-05	CcSEcCtD
Lansoprazole—Nausea—Doxorubicin—lung cancer	1.02e-05	7.83e-05	CcSEcCtD
Lansoprazole—ABCG2—Metabolism—PIK3CG—lung cancer	2.93e-06	3.49e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.93e-06	3.48e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GSTP1—lung cancer	2.91e-06	3.46e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTEN—lung cancer	2.9e-06	3.45e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NCOA3—lung cancer	2.89e-06	3.44e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP2E1—lung cancer	2.89e-06	3.44e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.89e-06	3.44e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—STK11—lung cancer	2.88e-06	3.43e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTA4—lung cancer	2.87e-06	3.41e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NQO1—lung cancer	2.86e-06	3.4e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.84e-06	3.38e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CD—lung cancer	2.84e-06	3.37e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CAT—lung cancer	2.83e-06	3.37e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP2E1—lung cancer	2.82e-06	3.35e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.82e-06	3.35e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ADCY1—lung cancer	2.81e-06	3.35e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCG2—lung cancer	2.81e-06	3.35e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ALB—lung cancer	2.8e-06	3.33e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.8e-06	3.33e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTA2—lung cancer	2.79e-06	3.32e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—POMC—lung cancer	2.79e-06	3.32e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NQO1—lung cancer	2.79e-06	3.32e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.77e-06	3.3e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—EP300—lung cancer	2.76e-06	3.29e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HPGDS—lung cancer	2.76e-06	3.29e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ENO2—lung cancer	2.76e-06	3.29e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ABCB1—lung cancer	2.76e-06	3.28e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPP2R1B—lung cancer	2.74e-06	3.26e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CREBBP—lung cancer	2.72e-06	3.24e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.71e-06	3.22e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.71e-06	3.22e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—TYMS—lung cancer	2.71e-06	3.22e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTA1—lung cancer	2.7e-06	3.21e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTT1—lung cancer	2.68e-06	3.19e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GSTM1—lung cancer	2.67e-06	3.18e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTP1—lung cancer	2.67e-06	3.18e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCC3—lung cancer	2.66e-06	3.17e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	2.66e-06	3.16e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP2E1—lung cancer	2.66e-06	3.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP2A6—lung cancer	2.65e-06	3.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GCLC—lung cancer	2.65e-06	3.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.64e-06	3.14e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP2E1—lung cancer	2.63e-06	3.13e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NQO1—lung cancer	2.63e-06	3.13e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NQO1—lung cancer	2.6e-06	3.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CAT—lung cancer	2.6e-06	3.09e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.58e-06	3.07e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKR1C1—lung cancer	2.58e-06	3.07e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CD—lung cancer	2.58e-06	3.07e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—STK11—lung cancer	2.57e-06	3.06e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.55e-06	3.03e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALB—lung cancer	2.55e-06	3.03e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.53e-06	3.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ABCB1—lung cancer	2.53e-06	3.01e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ERCC2—lung cancer	2.51e-06	2.99e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—STK11—lung cancer	2.51e-06	2.99e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ENO1—lung cancer	2.51e-06	2.99e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—UGT1A1—lung cancer	2.51e-06	2.98e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.5e-06	2.97e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—TYMS—lung cancer	2.48e-06	2.95e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CB—lung cancer	2.47e-06	2.94e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.47e-06	2.94e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTM1—lung cancer	2.45e-06	2.92e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—lung cancer	2.45e-06	2.91e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.42e-06	2.88e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GNG11—lung cancer	2.42e-06	2.88e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTP1—lung cancer	2.38e-06	2.83e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—STK11—lung cancer	2.37e-06	2.82e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—STK11—lung cancer	2.35e-06	2.79e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PIK3CA—lung cancer	2.34e-06	2.78e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTP1—lung cancer	2.32e-06	2.77e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP1A1—lung cancer	2.32e-06	2.77e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CAT—lung cancer	2.32e-06	2.76e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ERCC2—lung cancer	2.31e-06	2.74e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.3e-06	2.74e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALDOA—lung cancer	2.3e-06	2.74e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CAT—lung cancer	2.26e-06	2.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCB1—lung cancer	2.25e-06	2.68e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP2E1—lung cancer	2.25e-06	2.68e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CB—lung cancer	2.25e-06	2.68e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NCOA3—lung cancer	2.23e-06	2.66e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—lung cancer	2.23e-06	2.65e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NQO1—lung cancer	2.23e-06	2.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—TYMS—lung cancer	2.21e-06	2.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.2e-06	2.62e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTP1—lung cancer	2.19e-06	2.61e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTM1—lung cancer	2.19e-06	2.6e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.18e-06	2.59e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOA1—lung cancer	2.18e-06	2.59e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCG2—lung cancer	2.17e-06	2.59e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ADCY1—lung cancer	2.17e-06	2.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTP1—lung cancer	2.17e-06	2.58e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—TYMS—lung cancer	2.16e-06	2.57e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.16e-06	2.57e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTM1—lung cancer	2.14e-06	2.54e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTEN—lung cancer	2.14e-06	2.54e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CAT—lung cancer	2.13e-06	2.54e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HPGDS—lung cancer	2.13e-06	2.54e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ENO2—lung cancer	2.13e-06	2.54e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.12e-06	2.52e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CAT—lung cancer	2.11e-06	2.52e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.1e-06	2.5e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.08e-06	2.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP1A1—lung cancer	2.07e-06	2.47e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCB1—lung cancer	2.07e-06	2.47e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTT1—lung cancer	2.07e-06	2.46e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ERCC2—lung cancer	2.06e-06	2.45e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCB1—lung cancer	2.06e-06	2.45e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CA—lung cancer	2.04e-06	2.43e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCLC—lung cancer	2.04e-06	2.43e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP2A6—lung cancer	2.04e-06	2.43e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TYMS—lung cancer	2.04e-06	2.42e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—EP300—lung cancer	2.04e-06	2.42e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP1A1—lung cancer	2.03e-06	2.41e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TYMS—lung cancer	2.02e-06	2.4e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTM1—lung cancer	2.01e-06	2.4e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ERCC2—lung cancer	2.01e-06	2.39e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—STK11—lung cancer	2.01e-06	2.39e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTM1—lung cancer	2e-06	2.38e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOA1—lung cancer	1.99e-06	2.37e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CG—lung cancer	1.99e-06	2.36e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTEN—lung cancer	1.94e-06	2.31e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ENO1—lung cancer	1.94e-06	2.3e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.91e-06	2.27e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AKT1—lung cancer	1.91e-06	2.27e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP1A1—lung cancer	1.91e-06	2.27e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ERCC2—lung cancer	1.89e-06	2.25e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP1A1—lung cancer	1.89e-06	2.25e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—POMC—lung cancer	1.89e-06	2.25e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.88e-06	2.24e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ERCC2—lung cancer	1.88e-06	2.23e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTP1—lung cancer	1.86e-06	2.21e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—EP300—lung cancer	1.85e-06	2.2e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CREBBP—lung cancer	1.84e-06	2.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CG—lung cancer	1.82e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CAT—lung cancer	1.81e-06	2.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.8e-06	2.14e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOA1—lung cancer	1.78e-06	2.12e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCB1—lung cancer	1.76e-06	2.09e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CD—lung cancer	1.75e-06	2.08e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOA1—lung cancer	1.74e-06	2.07e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP2E1—lung cancer	1.74e-06	2.07e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—POMC—lung cancer	1.73e-06	2.06e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TYMS—lung cancer	1.73e-06	2.05e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—lung cancer	1.72e-06	2.05e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NQO1—lung cancer	1.72e-06	2.04e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTM1—lung cancer	1.71e-06	2.03e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.7e-06	2.03e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CREBBP—lung cancer	1.69e-06	2.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AKT1—lung cancer	1.67e-06	1.99e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOA1—lung cancer	1.64e-06	1.95e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CG—lung cancer	1.63e-06	1.93e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOA1—lung cancer	1.62e-06	1.93e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP1A1—lung cancer	1.62e-06	1.92e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ERCC2—lung cancer	1.6e-06	1.91e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CD—lung cancer	1.6e-06	1.9e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CG—lung cancer	1.59e-06	1.89e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—lung cancer	1.58e-06	1.88e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.55e-06	1.85e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—STK11—lung cancer	1.55e-06	1.84e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—POMC—lung cancer	1.55e-06	1.84e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CB—lung cancer	1.52e-06	1.81e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—POMC—lung cancer	1.51e-06	1.8e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—lung cancer	1.51e-06	1.79e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CREBBP—lung cancer	1.51e-06	1.79e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CA—lung cancer	1.51e-06	1.79e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CG—lung cancer	1.49e-06	1.78e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CG—lung cancer	1.48e-06	1.76e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CREBBP—lung cancer	1.47e-06	1.75e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTP1—lung cancer	1.43e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CD—lung cancer	1.43e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—POMC—lung cancer	1.42e-06	1.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—POMC—lung cancer	1.41e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—lung cancer	1.41e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CB—lung cancer	1.4e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CD—lung cancer	1.39e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CAT—lung cancer	1.39e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOA1—lung cancer	1.39e-06	1.65e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CREBBP—lung cancer	1.39e-06	1.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—lung cancer	1.38e-06	1.65e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—lung cancer	1.38e-06	1.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CREBBP—lung cancer	1.37e-06	1.64e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CA—lung cancer	1.37e-06	1.63e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCB1—lung cancer	1.36e-06	1.61e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TYMS—lung cancer	1.33e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.33e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTM1—lung cancer	1.32e-06	1.57e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTEN—lung cancer	1.32e-06	1.57e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CD—lung cancer	1.31e-06	1.56e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CD—lung cancer	1.3e-06	1.55e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—lung cancer	1.3e-06	1.54e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—lung cancer	1.29e-06	1.53e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CG—lung cancer	1.27e-06	1.51e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—EP300—lung cancer	1.25e-06	1.49e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP1A1—lung cancer	1.25e-06	1.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CB—lung cancer	1.25e-06	1.48e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ERCC2—lung cancer	1.24e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—lung cancer	1.23e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AKT1—lung cancer	1.23e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CB—lung cancer	1.22e-06	1.45e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTEN—lung cancer	1.21e-06	1.43e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—POMC—lung cancer	1.21e-06	1.43e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—lung cancer	1.2e-06	1.43e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CREBBP—lung cancer	1.17e-06	1.4e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—EP300—lung cancer	1.15e-06	1.37e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CB—lung cancer	1.15e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CB—lung cancer	1.14e-06	1.35e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—lung cancer	1.13e-06	1.35e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—lung cancer	1.13e-06	1.34e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AKT1—lung cancer	1.12e-06	1.33e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CD—lung cancer	1.11e-06	1.32e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—lung cancer	1.1e-06	1.31e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTEN—lung cancer	1.08e-06	1.28e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOA1—lung cancer	1.07e-06	1.27e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTEN—lung cancer	1.05e-06	1.25e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—EP300—lung cancer	1.03e-06	1.22e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—EP300—lung cancer	1e-06	1.19e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTEN—lung cancer	9.9e-07	1.18e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTEN—lung cancer	9.81e-07	1.17e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CG—lung cancer	9.77e-07	1.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CB—lung cancer	9.7e-07	1.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—lung cancer	9.61e-07	1.14e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—EP300—lung cancer	9.44e-07	1.12e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—EP300—lung cancer	9.36e-07	1.11e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—POMC—lung cancer	9.3e-07	1.11e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CA—lung cancer	9.28e-07	1.1e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CREBBP—lung cancer	9.06e-07	1.08e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CD—lung cancer	8.59e-07	1.02e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CA—lung cancer	8.51e-07	1.01e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—lung cancer	8.48e-07	1.01e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTEN—lung cancer	8.38e-07	9.98e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—EP300—lung cancer	8e-07	9.52e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CA—lung cancer	7.59e-07	9.03e-06	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKT1—lung cancer	7.58e-07	9.02e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CB—lung cancer	7.49e-07	8.91e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—lung cancer	7.42e-07	8.83e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CA—lung cancer	7.41e-07	8.82e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CA—lung cancer	6.98e-07	8.31e-06	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKT1—lung cancer	6.95e-07	8.27e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CA—lung cancer	6.92e-07	8.24e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTEN—lung cancer	6.47e-07	7.7e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKT1—lung cancer	6.2e-07	7.38e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—EP300—lung cancer	6.17e-07	7.34e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKT1—lung cancer	6.05e-07	7.2e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CA—lung cancer	5.92e-07	7.04e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKT1—lung cancer	5.7e-07	6.79e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKT1—lung cancer	5.65e-07	6.73e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKT1—lung cancer	4.83e-07	5.75e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CA—lung cancer	4.57e-07	5.43e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKT1—lung cancer	3.73e-07	4.44e-06	CbGpPWpGaD
